Conclusion
SOC reduced tremor
This is the first randomized large-scale pragmatic clinical trial to evaluate unsupervised TAPS use in a real-world home-base setting. The study demonstrated that adding TAPS therapy to existing SOC reduced tremor power and increased improvements in BF-ADL upper limb scores during one month of home use compared to SOC alone. These findings expand and reinforce the prospective and real-world studies suggesting TAPS is a safe and effective treatment option for patients with ET.